Cat. #151860
Integrin AvB6 inhibiting Peptide
Cat. #: 151860
Sub-type: Inhibitor
Availability: Please enquire for quantities and pricing
Target: Integrin AvB6 inhibiting peptide
Function: Inhibitor
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: John Marshall
Institute: Queen Mary University of London
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: Integrin AvB6 inhibiting Peptide
- Research fields: Cancer;Cell biology
- Tool sub type: Inhibitor
- Source: HEK293
- Target: Integrin AvB6 inhibiting peptide
- Description: av?6 is a major new target for molecular-specific imaging and therapy of cancer. It is expressed only on epithelia and then usually only during processes of tissue remodelling; these include wound healing, chronic inflammation, and cancer. The av?6 inhibiting peptide could not only permit diagnostic imaging, but also to deliver anticancer therapy specifically to tumour cells while sparing local normal tissues.
- Function: Inhibitor
Handling
- Shipping conditions: Dry Ice
Target Details
- Target: Integrin AvB6 inhibiting peptide
References
- Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.
- High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.
